Co-Diagnostics, Inc.

$1.11Close · Oct 9, 2026

News

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week
Sep 23, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation
Sep 21, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026
Sep 17, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola
Sep 16, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics to Hold Press Conference
Sep 15, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida
Sep 10, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India
Sep 3, 2026Investors | Co-Diagnostics, Inc.
Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base
Sep 1, 2026Investors | Co-Diagnostics, Inc.
Co-Dx Fireside Chat with KCSA
Nov 5, 2025Co-Dx
On November 5, 2025, Co-Dx CEO Dwight Egan chatted with Valter Pinto from KCSA to discuss company growth trajectory following recently-announced initiatives, including CoMira Diagnostics (the new joint venture in Saudi Arabia), the new Co-Dx AI business unit, and the company’s plans to pursue a SPAC transaction for CoSara Diagnostics in India. The post Co-Dx Fireside Chat with KCSA appeared first on Co-Dx.
Nasdaq Live from MarketSite Interview with Dwight Egan
Mar 3, 2025Co-Dx
On January 14, 2025, CEO Dwight Egan sat down with Nasdaq Listings host Kristina Ayanian at the Silicon Slopes Summit to discuss the company, its upcoming platform, and its mission. The post Nasdaq Live from MarketSite Interview with Dwight Egan appeared first on Co-Dx.